Bank Julius Baer & Co
NVAX icon

Bank Julius Baer & Co’s Novavax NVAX Stock Holding History

Bank Julius Baer & Co’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,500
Closed -$108K – 693
2025
Q3 		$108K Hold
12,500
– – ﹤0.01% 531
2025
Q2 		$78.7K Hold
12,500
– – ﹤0.01% 516
2025
Q1 		$80.1K Buy
+12,500
New +$103K ﹤0.01% 506
2022
Q1 		– Sell
-3,258
Closed -$466K – 730
2021
Q4 		$466K Sell
3,258
-4,142
-56% -$712K ﹤0.01% 429
2021
Q3 		$1.54M Buy
7,400
+4,409
+147% +$972K 0.01% 280
2021
Q2 		$635K Buy
2,991
+2,641
+755% +$484K ﹤0.01% 413
2021
Q1 		$64K Sell
350
-5,183
-94% -$1.03M ﹤0.01% 649
2020
Q4 		$617K Buy
5,533
+33
+0.6% +$3.51K 0.01% 423
2020
Q3 		$596K Sell
5,500
-1,869
-25% -$228K 0.01% 357
2020
Q2 		$617K Sell
7,369
-30,048
-80% -$1.15M 0.01% 332
2020
Q1 		$508K Buy
+37,417
New +$317K 0.01% 311

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank Julius Baer & Co's NVAX Position: Q4 2025 in Review

Bank Julius Baer & Co sold out of Novavax (NVAX) in Q4 2025, closing a stake of 12,500 shares — an estimated $108K sold.

Bank Julius Baer & Co first reported a position in NVAX in Q1 2020 and held it in 11 quarters. The position peaked at $1.54M in Q3 2021. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Bank Julius Baer & Co reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Bank Julius Baer & Co sold 12,500 Novavax shares in Q4 2025, an estimated $108K.
  • Bank Julius Baer & Co first reported a position in Novavax in Q1 2020 and held it in 11 quarters.
  • Bank Julius Baer & Co's Novavax position peaked at $1.54M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Bank Julius Baer & Co's 13F filing for Q4 2025, filed 5 Feb 2026.